NR
Nihar Ranjan Mohanty
About Nihar Ranjan Mohanty
Data last updated:
Nihar Ranjan Mohanty is a Director at Tridax Health Science And Research Private Limited (since 2017). The company operates in Non-Profit Organizations. Tridax Health Science And Research Private Limited reported revenue of ₹2.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Aug 2017 | 2017 | ₹2.7 Lakh (FY 2025) | Active |
Board colleagues of Nihar Ranjan Mohanty
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bansidhar Mulia | 07822229 | Tridax Health Science And Research Private Limited | Director |
| Deepak Kumar Parida | 07851061 | Tridax Health Science And Research Private Limited | Director |
| Saumitra Kumar Satapathy | 07851019 | Tridax Health Science And Research Private Limited | Director |
| Sultan Kabiruddin Khan | 07851099 | Tridax Health Science And Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nihar Ranjan Mohanty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nihar Ranjan Mohanty
Nihar Ranjan Mohanty currently holds 1 directorship: Tridax Health Science And Research Private Limited (Director, since 16 Aug 2017, revenue ₹2.7 Lakh (FY 2025)).
Nihar Ranjan Mohanty was first appointed on 16 Aug 2017 as Director at Tridax Health Science And Research Private Limited.
The current boards of Nihar Ranjan Mohanty's companies include Bansidhar Mulia (Tridax Health Science And Research Private Limited), Deepak Kumar Parida (Tridax Health Science And Research Private Limited), Saumitra Kumar Satapathy (Tridax Health Science And Research Private Limited), Sultan Kabiruddin Khan (Tridax Health Science And Research Private Limited).